The Global Antidiarrheal Drugs market is expected to be around US$ 3080 Million by 2028 at a CAGR of 3.1% in the given forecast period.
The increasing incidence of diarrhea across the globe is the primary growth driver for this market. Globally, around 2 billion cases of diarrheic disease occur each year. Diarrhea presents the next risk for people higher than 65 years recent and youngsters under five years. The increasing incidence of the diarrheal disease is creating a demand for Antidiarrheal Drugs, thereby, leading to market growth.
Antidiarrheal drugs are used to treat abrupt diarrhea and possess the mechanism of slowing down the movement of the gut and helps to diminish the number of bowel movements and also make the stools less watery. Distinct causes of diarrhea can be a virus such as a rotavirus, hepatitis, a bacterium such as E.coli, Shigella, and parasites causing amoebiasis and giardiasis. Majority of the events of diarrhea are recognized to be concluded with simple dietary modifications and may not require treatment, however, in certain cases of severe diarrhea, laboratory assessment is requisite which includes blood tests, and stool specimen evaluation to analyze the type of diarrhea.
The global Antidiarrheal Drugs market is segregated on the basis of Application as Adults and Children. Based on Type the global Antidiarrheal Drugs market is segmented in OTC Drugs and Prescription Drugs.
The global Antidiarrheal Drugs market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Antidiarrheal Drugs market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
GlaxoSmithKline, Pfizer, GSK, Lupin, Glenmark Pharmaceuticals, Sanofi Aventis, Lupin and others are among the major players in the global Antidiarrheal Drugs market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Antidiarrheal Drugs Market has been segmented as below:
Antidiarrheal Drugs Market, By Application
Antidiarrheal Drugs Market, By Type
Antidiarrheal Drugs Market, By Region
Antidiarrheal Drugs Market, By Company
The report covers:
Report Scope:
The global Antidiarrheal Drugs market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Antidiarrheal Drugs market share. Major industry players with significant revenue share include GlaxoSmithKline, Proctor & Gamble, Pfizer, Actelion, Perrigo, Lupin, Glenmark Pharmaceuticals, Sanofi Aventis, Merck & Co., Novartis, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Topical Use Acne Treatment Market
Surgical Drains/Wound Drainage Market
Orally Disintegrating Tablet (ODT) market
1 INTRODUCTION
1.1 Key Points
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 List of Abbreviation
2 RESEARCH METHODOLOGY
2.1 Research Scope
2.2 Research Methodology
2.2.1 Market Research Process
2.2.2 Market Research Methodology
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 Introduction
4.2 Drivers
4.2.1 Rise in Diarrheal Disease
4.2.2 Rising Government Initiatives for Improvement in Healthcare Facilities
4.3 Restraints
4.3.1 Side Effects of Anti-Diarrheal Drugs
5 ANTIDIARRHEAL DRUGS MARKET, BY TYPE
5.1 Key Points
5.2 Prescription Drugs
5.3 OTC
6 ANTIDIARRHEAL DRUGS MARKET, BY APPLICATION
6.1 Key Points 46
6.2 Children 48
6.3 Adults 50
7 ANTIDIARRHEAL DRUGS MARKET, BY REGION
7.1 Key Points
7.2 Asia Pacific
7.2.1 China
7.2.2 India
7.2.3 Japan
7.2.4 Rest of Asia Pacific
7.3 Europe
7.3.1 Germany
7.3.2 France
7.3.3 U. K
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 North America
7.4.1 U. S
7.4.2 Canada
7.5 Rest of World
8 COMPANY PROFILES
8.1 Perrigo Company PLC
8.1.1 Company Overview
8.1.2 Financial Landscape
8.1.3 Product/Service Landscape
8.2 Cipla Limited
8.2.1 Company Overview
8.2.2 Financial Landscape
8.2.3 Product/Service Landscape
8.3 GSK
8.3.1 Company Overview
8.3.2 Financial Landscape
8.3.3 Product/Service Landscape
8.4 Glenmark Pharmaceuticals
8.4.1 Company Overview
8.4.2 Financial Landscape
8.4.3 Product/Service Landscape
8.5 Janssen
8.5.1 Company Overview
8.5.2 Financial Landscape
8.5.3 Product/Service Landscape
8.6 Lupin
8.6.1 Company Overview
8.6.2 Financial Landscape
8.6.3 Product/Service Landscape
8.7 Bayer
8.7.1 Company Overview
8.7.2 Financial Landscape
8.7.3 Product/Service Landscape
8.8 Sanofi
8.8.1 Company Overview
8.8.2 Financial Landscape
8.8.3 Product/Service Landscape
8.9 Pfizer Inc.
8.9.1 Company Overview
8.9.2 Financial Landscape
8.9.3 Product/Service Landscape
The Antidiarrheal Drugs Market has been segmented as below:
Antidiarrheal Drugs Market, By Application
Antidiarrheal Drugs Market, By Type
Antidiarrheal Drugs Market, By Region
Antidiarrheal Drugs Market, By Company
